Sep. 23 at 11:22 PM
$BHVN Took some profit from
$MYO and
$BMA +20% in a couple days to average down here. Average now 14.7
Multiple catalysts to double from here by EoY. Approval, depression data, and
$XENE data. Biohaven's drug outperformed Xenon in early trials and Biohaven is worth half of Xenon right now